Sign Out
Each 120 mg vial contains 120 mg of belimumab. Each 400 mg vial contains 400 mg of belimumab. After reconstitution, the solution contains 80 mg belimumab per ml.
Each 1-ml pre-filled pen contains 200 mg of belimumab.
Belimumab is a human, IgG1λ monoclonal antibody, produced in a mammalian cell line (NS0) by recombinant DNA technology.
Excipients/Inactive Ingredients: Powder for concentrate for solution for infusion: Citric acid monohydrate (E330), Sodium citrate (E331), Sucrose, Polysorbate 80.
Solution for injection: L-arginine hydrochloride, L-histidine, L-histidine monohydrochloride, Polysorbate 80, Sodium chloride, Water for injection.
